Evidence map›Paper›PMID 33088465›Full record

ArticleInternational journal of preventive medicine2020

Methodology and Early Results of the First Surveillance Program on Prevention and Control of Antimicrobial Resistance in Isfahan, Iran: The IAS-I Study.

Sayed Nasser Mostafavi, Soodabeh Rostami, Behrooz Ataei, Sina Mobasherizadeh, Azam Cheraghi, Somayeh Haghighipour, Samereh Nouri, Arezoo Pourdad, Parisa Ataabadi, Naser Almasi and 16 more

Open access · goldAbstract read
In one paragraph

Article in International journal of preventive medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 3 institutions in 1 country.

Sayed Nasser MostafaviInfectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Soodabeh RostamiNosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Behrooz AtaeiInfectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Sina MobasherizadehNosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Azam CheraghiDepartment of Hospitals Supervision and Accreditation, Vice-Chancellery for Clinical Affairs, Isfahan University of Medical Sciences, Isfahan, Iran.
Somayeh HaghighipourInfectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Samereh NouriDepartment of Microbiology, Clinical Laboratory of Alzahra Medical Center, Isfahan, Iran.
Arezoo PourdadAlzahra Medical Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Parisa AtaabadiAlzahra Medical Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Naser AlmasiDepartment of Microbiology, Clinical Laboratory of Dr. Shariati Hospital, Isfahan Social Security Organization, Isfahan, Iran.
Leila HeidaryDepartment of Microbiology, Clinical Laboratory of Dr. Shariati Hospital, Isfahan Social Security Organization, Isfahan, Iran.
Kourosh NaderiDepartment of Microbiology, Clinical Laboratory of Dr. Shariati Hospital, Isfahan Social Security Organization, Isfahan, Iran.
Setareh KorangbeheshtiDepartment of Microbiology, Clinical Laboratory of Dr. Shariati Hospital, Isfahan Social Security Organization, Isfahan, Iran.
Shiva NavabiDepartment of Microbiology, Clinical Laboratory of Dr. Gharazi Hospital, Isfahan Social Security Organization, Isfahan, Iran.
Laleh MasssahDepartment of Microbiology, Clinical Laboratory of Dr. Gharazi Hospital, Isfahan Social Security Organization, Isfahan, Iran.
Zohreh NorouziDepartment of Microbiology, Clinical Laboratory of Dr. Gharazi Hospital, Isfahan Social Security Organization, Isfahan, Iran.
Mehrnoush BakhtiyaritabarDepartment of Microbiology, Clinical Laboratory of Dr. Gharazi Hospital, Isfahan Social Security Organization, Isfahan, Iran.
Saeed MoayedniaDepartment of Microbiology, Clinical Laboratory of Alzahra Medical Center, Isfahan, Iran.
Dariush ShokriNosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Mahin MikhakDepartment of Microbiology, Clinical Laboratory of Dr. Shariati Hospital, Isfahan Social Security Organization, Isfahan, Iran.
Majid RahmaniDepartment of Microbiology, Clinical Laboratory of Dr. Gharazi Hospital, Isfahan Social Security Organization, Isfahan, Iran.
Mohammad HashemiCardiovascular Department, Interventional Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Reza EtminaniDepartment of Hospitals Supervision and Accreditation, Vice-Chancellery for Clinical Affairs, Isfahan University of Medical Sciences, Isfahan, Iran.
Nasrin AhmadiVice-Chancellery for Clinical Affairs, Isfahan Social Security Organization, Isfahan, Iran.
Mahboubeh AkhlaghiStudent Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran.
Roya KelishadiChild Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
Isfahan University of Medical Sciences · IRShariati Hospital · IRAlzahra Medical and Education Center · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIsfahan Antibiotic Resistance Surveillance System-1 has been instituted in Isfahan, Iran to construct a project for surveillance of clinically significant bacteria, and to help raise a logic regional stewardship program for prevention and control of disseminating-resistant organisms.

methodsDuring March 2016 to March 2018, an antibiotic resistance surveillance system was designed and implemented by Isfahan Infectious Diseases and Tropical Medicine Research Center. The surveillance program was implemented in three general hospitals in Isfahan. In addition to the routine microbiology data, clinical data (differentiation between true infections and contamination, healthcare-associated infections (HCAI) and community-acquired infections (CAI), as well as determination of the infection site) were obtained and analyzed by WHONET software.

resultsDuring a 2-year period, from 7056 samples that revealed growth of bacteria, 3632 (51.5%) isolates were detected as contamination and 3424 (48.5%) true bacterial isolates were identified. Of these, about 32% of isolates were recognized as HCAI. Totally, the most recognized infections were urinary tract infection, bloodstream infection and skin and soft tissue infections. In patients with HCAIs, 70% of isolates were gram negative and in patients with CAIs 73% isolates were gram negative bacteria.

conclusionsThe strength of the project is gathering enough clinical information in addition to microbiologic data, which would increase application of the results for empiric treatment and prevention of the infectious diseases in clinical settings.

Indexed as

Bacteriadrug resistanceepidemiologyIranmethods

Identifiers

PMID33088465
PMCPMC7554560
OpenAlexW3083754014

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.